Net Income (Quarterly) Chart

Historical Net Income (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
September 30, 2026 39.59M
June 30, 2026 30.95M
March 31, 2026 8.841M
December 31, 2025 -39.77M
September 30, 2025 6.626M
June 30, 2025 -8.691M
March 31, 2025 -3.484M
December 31, 2024 -19.95M
September 30, 2024 -7.888M
June 30, 2024 -11.05M
March 31, 2024 -10.92M
December 31, 2023 -7.967M
September 30, 2023 -7.339M
June 30, 2023 -6.216M
March 31, 2023 -5.739M
December 31, 2022 -6.123M
September 30, 2022 -7.309M
June 30, 2022 -7.239M
March 31, 2022 -7.340M
Date Value
December 31, 2021 2.983M
September 30, 2021 -5.569M
June 30, 2021 -4.841M
March 31, 2021 -5.352M
December 31, 2020 -4.207M
September 30, 2020 -5.096M
June 30, 2020 -5.016M
March 31, 2020 -5.451M
December 31, 2019 -5.242M
September 30, 2019 -4.649M
June 30, 2019 -5.334M
March 31, 2019 -5.932M
December 31, 2018 -6.183M
September 30, 2018 -4.321M
June 30, 2018 -3.319M
March 31, 2018 -3.430M
December 31, 2017 -2.162M
March 31, 2017 -1.106M
December 31, 2016 -1.157M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Quarterly) Range, Past 5 Years

View Net Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Quarterly) Benchmarks

View Net Income (Quarterly) Benchmarks
Start Trial
EyePoint, Inc. -95.61M
ANI Pharmaceuticals, Inc. 32.72M
Corcept Therapeutics, Inc. 124.49M
Veru, Inc. -6.988M
Johnson & Johnson 210.00M

Net Income (Quarterly) Related Metrics